Stay updated on NSCLC Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the NSCLC Immunotherapy Clinical Trial page.

Latest updates to the NSCLC Immunotherapy Clinical Trial page
- Check2 days agoChange DetectedA new PubMed citation has been added to the Publications section for the study: Nishio M, Hayashi H, Goto Y, et al. Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis. Int J Clin Oncol. 2026 Aug 11. doi: 10.1007/s10147-026-03116-w. Online ahead of print.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision update to v3.6.5 is shown alongside deletions that remove access to study documents, sponsor details, and related terms on the page, altering how the trial's materials and context are presented.SummaryDifference16%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a small internal update to the page without modifying the displayed study information.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page revision tag changed from v3.6.1 to v3.6.3, signaling a small update to the page's backend or formatting without altering the study information.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision was updated from v3.6.0 to v3.6.1, indicating a minor platform update. This change does not alter the study details or other user-visible content.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4, indicating a minor update to the page’s metadata/versioning rather than altering the study content.SummaryDifference0.0%

Stay in the know with updates to NSCLC Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Immunotherapy Clinical Trial page.